In uncontrolled asthma, adding glycopyrronium to budesonide–formoterol reduced annualized severe exacerbations
- 1 June 2026
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 179 (6) , JC69
Abstract
GIM/FP/GP: [Formula: see text] Allerg & Immunol: [Formula: see text] Pulmonology: [Formula: see text].Keywords
This publication has 2 references indexed in Scilit:
- Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trialThe Lancet Respiratory Medicine, 2021
- Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trialsThe Lancet, 2019